Genesis Biopharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Genesis Biopharma Inc
TickerIOVA
CIK #0001425205
CUSIP462260100
SectorEnergy & Transportation - Arrangement Of Transportation Of Freight & Cargo
Address1601 N Sepulveda Blvd, #632, Manhattan Beach, CA 90266
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Lion Biotechnologies Inc 2016-06-15 100.0 M Exemption: 506(b) · Duration: One year or less · Commission: $4,000,000 · Revenue: No Revenues
Genesis Biopharma Inc 2013-06-06 1.4 M Exemption: 506 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001425205] 10-K
[0001425205] 10-Q
[0001425205] 3
[0001425205] 4
[0001425205] 5
[0001425205] 8-K
[0001425205] D
[0001425205] SC 13D
[0001425205] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Iovance Biotherapeutics Inc [2026-05-12] 0.0
State Street Corp Iovance Biotherapeutics Inc [2026-02-09] 0.0
Perceptive Advisors LLC Iovance Biotherapeutics Inc [2024-03-01] 81946.9
Point72 Asset Management LP Iovance Biotherapeutics Inc [2023-02-17] 4.6
BlackRock Inc Iovance Biotherapeutics Inc [2023-02-03] 7.7
State Street Corp Iovance Biotherapeutics Inc [2023-02-02] 9.32
MHR Fund Management LLC Iovance Biotherapeutics Inc [2022-12-30] 5.8
Wellington Management Group LLP Iovance Biotherapeutics Inc [2022-02-04] 6.11
Ark Investment Management LLC Iovance Biotherapeutics Inc [2021-01-11] 10.43
Price T Rowe Associates Inc /MD/ Iovance Biotherapeutics Inc [2020-02-14] 5.1
Vanguard Group Inc Iovance Biotherapeutics Inc [2020-02-11] 8.6
Perceptive Advisors LLC Iovance Biotherapeutics Inc [2019-02-14] 9.9
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2019-02-14] 2.5
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2018-02-14] 5.4
Broadfin Capital LLC Iovance Biotherapeutics Inc [2018-02-13] 6.75
BlackRock Inc Iovance Biotherapeutics Inc [2018-01-25] 6.7
OrbiMed Advisors LLC Lion Biotechnologies Inc [2017-02-13] 3.92
Acuta Capital Partners LLC Lion Biotechnologies Inc [2017-02-13] 6.1
Franklin Resources Inc Lion Biotechnologies Inc [2017-02-07] 8.4
Quogue Capital LLC Lion Biotechnologies Inc [2016-06-13] 0.6
venBio Select Advisor LLC Lion Biotechnologies Inc [2016-02-12] 6.7
RS Investment Management Co LLC Lion Biotechnologies Inc [2016-02-12] 5.55
Broadfin Capital LLC Lion Biotechnologies Inc [2016-02-11] 7.31
BlackRock Inc Lion Biotechnologies Inc [2016-01-28] 6.6
Perceptive Advisors LLC Lion Biotechnologies Inc [2015-02-17] 0.76
FMR LLC Lion Biotechnologies Inc [2014-07-10] 0.0
Alpha Capital Anstalt Lion Biotechnologies Inc [2014-01-02] 7.197
Ayer Capital Management LP Genesis Biopharma Inc [2013-06-03] 40.47
[2013-01-09] None
Form 3/4/5 Filer 2011 - 2026
Puri Raj K
Iovance Biotherapeutics Inc
Maynard Ryan D
Countouriotis Athena
Dukes Iain D
Weiser Michael
Vogt Frederick G
Graf Finckenstein Friedrich
Bilinsky IGOR
Kirby Daniel Gordon
Roche Corleen M
Rosinack Matthew W
Yarno Wendy L
Bellemin Jean-Marc
Rothbaum Wayne P
McPeak Merrill A
Dixon Wendy L
Swartzburg Michael
Fardis Maria
Morris Timothy E
Venkatesan Jay
Hillsberg Sanford
Valle Franco
Schiffman Gregory T
Henderson Molly
Fischkoff Steven A
Lotze Michael
Hawkins ELMA
Bender James G
ACM Capital Partners LLC
Ayer Capital Management LP
Ayer Capital Partners LLC
Radvanyi Laszlo
Handelman Michael D
Bristol Investment Fund Ltd
Bristol Capital LLC
Singh Manish
Voyticky David J
Kessler Paul L
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Graf Finckenstein Friedrich
Restricted Stock Units · derivative
2026-03-09 Grant 58,750 $0.00
Roche Corleen M
Restricted Stock Units · derivative
2026-03-09 Grant 132,200 $0.00
Bilinsky IGOR
Restricted Stock Units · derivative
2026-03-09 Grant 117,500 $0.00
Kirby Daniel Gordon
Restricted Stock Units · derivative
2026-03-09 Grant 132,200 $0.00
Puri Raj K
Restricted Stock Units · derivative
2026-03-09 Grant 117,500 $0.00
Vogt Frederick G
Restricted Stock Units · derivative
2026-03-09 Grant 235,000 $0.00
Graf Finckenstein Friedrich
Common Stock
2026-03-05 Tax withheld 16,520 $4.58 75,662
Bilinsky IGOR
Common Stock
2026-03-05 Tax withheld 16,628 $4.58 76,156
Graf Finckenstein Friedrich
Common Stock
2026-03-05 Option exercise 31,246 $0.00
Puri Raj K
Restricted Stock Units · derivative
2026-03-05 Option exercise 39,059 $0.00
Puri Raj K
Common Stock
2026-03-05 Option exercise 39,059 $0.00
Vogt Frederick G
Restricted Stock Units · derivative
2026-03-05 Option exercise 62,493 $0.00
Puri Raj K
Common Stock
2026-03-05 Tax withheld 18,360 $4.58 84,089
Bilinsky IGOR
Common Stock
2026-03-05 Option exercise 31,246 $0.00
Vogt Frederick G
Common Stock
2026-03-05 Option exercise 62,493 $0.00
Graf Finckenstein Friedrich
Restricted Stock Units · derivative
2026-03-05 Option exercise 31,246 $0.00
Vogt Frederick G
Common Stock
2026-03-05 Tax withheld 26,755 $4.58 122,538
Bilinsky IGOR
Restricted Stock Units · derivative
2026-03-05 Option exercise 31,246 $0.00
Vogt Frederick G
Common Stock
2026-03-02 Tax withheld 22,809 $3.79 86,446
Vogt Frederick G
Restricted Stock Units · derivative
2026-03-02 Option exercise 10,418 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 289 268,989,087
2025-12-31 264 261,535,225
2025-09-30 254 217,679,935
2025-06-30 252 224,472,430
2025-03-31 305 236,919,137
2024-12-31 307 238,802,290
2024-09-30 292 233,637,547
2024-06-30 300 232,679,220
2024-03-31 284 224,545,530
2023-12-31 244 216,931,206
2023-09-30 233 217,557,698
2023-06-30 223 201,009,581
Form 13F Holdings
Firm Period DFND Voting Shares
Mirador Capital Partners LP [2026-06-30] SOLE 1,080,288 1,080,288
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 818,913 818,913
TEMA ETFS LLC [2026-06-30] SOLE 280,048 280,048
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 5,290 102,018
Centurion Wealth Management LLC [2026-06-30] SOLE 0 69,168
B Riley Wealth Advisors Inc [2026-06-30] SOLE 51,000 51,000
Assenagon Asset Management SA [2026-06-30] SOLE 46,842 46,842
Traphagen Investment Advisors LLC [2026-06-30] SOLE 0 38,962
Grimes & Company Inc [2026-06-30] SOLE 18,021 37,842
Sequoia Financial Advisors LLC [2026-06-30] SOLE 0 32,957
Brookstone Capital Management [2026-06-30] SOLE 0 22,607
Merit Financial Group LLC [2026-06-30] OTR 0 15,587
NorthCrest Asset Manangement LLC [2026-06-30] SOLE 890 13,028
Merit Financial Group LLC [2026-06-30] SOLE 55 9,249
Farther Finance Advisors LLC [2026-06-30] SOLE 0 7,093
Gamma Investing LLC [2026-06-30] DFND 5,422 5,422
Wealth Enhancement Trust Services Inc [2026-06-30] DFND 4,000 4,000
IFP Advisors LLC [2026-06-30] SOLE 1,611 1,611
First United Bank & Trust [2026-06-30] SOLE 1,000 1,000
True Wealth Design LLC [2026-06-30] SOLE 0 400
LRI Investments LLC [2026-06-30] SOLE 209 209
Fortitude Family Office LLC [2026-06-30] SOLE 61 61
FNY Investment Advisers LLC [2026-06-30] SOLE 6,000 5
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com